REACH
ENGAGE
CONVERGE

Optigage supports pharmaceutical/biotech companies and healthcare solution providers in tackling complex challenges specific to the Belgian market. Through research and advice, we help achieve them care gains.

Why clients turn to us

Our Services

We build capabilities for analysis and action

Our Value As a Partner for the Belgian market

  • Validate hypotheses and make fact-based decisions based on quantitative and/or qualitative research.
  • Customise research grounded in deep understanding of the Belgian market and each pharmaceutical company’s situation.
  • Define and clearly substantiate priorities to “sell” internally.
  • Translate insights into actions while also taking into account organisational impact and required change management.
  • Facilitate alignment in complex, multi-stakeholder collaborations.

On The Agenda: “How Healthcare Companies and Healthcare Practitioners Interact Best”

Get your complimentary copy of our “On The Agenda” White Paper and read it today. We welcome your feedback!

Data-Driven Multichannel Solutions for Healthcare & Pharma Marketing

Our team

News & updates

Stay up to date with the latest insights in healthcare and pharma marketing, and multichannel engagement. Discover Optigage’s research findings, expert perspectives, and company updates — all designed to help healthcare and pharma organisations boost reach, engagement, and conversion.

Three phases of a commercial phamra market access strategy

Pre-Launch Focus on specialist drugs prescribed by doctors in a specific field, who actively seek information to make evidence-based decisions (Vakratsas and Wang, 2023). Therefore, it is crucial to facilitate specialists who gain experience through clinical studies and who share their experience with colleagues as key opinion leaders (KOLs). This can be done through presentations